The impact of phospholipid transfer protein (PLTP) on HDL metabolism

被引:188
作者
Huuskonen, J [1 ]
Olkkonen, VM [1 ]
Jauhiainen, M [1 ]
Ehnholm, C [1 ]
机构
[1] Natl Publ Hlth Inst, Dept Biochem, SF-00300 Helsinki, Finland
关键词
PLTP; phospholipid transfer; HDL; lipoprotein metabolism; reverse cholesterol transport; atherosclerosis;
D O I
10.1016/S0021-9150(01)00447-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High-density lipoproteins (HDL) play a major protective role against the development of coronary artery disease. Phospholipid transfer protein (PLTP) is a main factor regulating the size and composition of HDL in the circulation and plays an important role in controlling plasma HDL levels. This is achieved via both the phospholipid transfer activity of PLTP and its capability to cause HDL conversion. The present review focuses on the impact of PLTP on HDL metabolism. The basic characteristics and structure of the PLTP protein are described. The two main functions of PLTP, PLTP-mediated phospholipid transfer acid HDL conversion are reviewed, and the mechanisms and control, as well as the physiological significance of these processes are discussed. The relationship between PLTP and the related cholesteryl ester transfer protein (CETP) is reviewed. Thereafter other functions of PLTP are recapitulated: the: ability of PLTP to transfer cholesterol, alpha -tocopherol and lipopolysaccharide (LPS). and the suggested involvement of PLTP in cellular cholesterol traffic. The discussion on PLTP activity and mass in (patho)physiological settings includes new data on the presence of two forms of PLTP in the circulation, one catalytically active and the other inactive. Finally. future directions for PLTP research are outlined. (C) 2001 Elsevier science Ireland Ltd. All rights reserved.
引用
收藏
页码:269 / 281
页数:13
相关论文
共 123 条
[1]   Transgenic mice expressing human phospholipid transfer protein have increased HDL non-HDL cholesterol ratio [J].
Albers, JJ ;
Tu, AY ;
Paigen, B ;
Chen, H ;
Cheung, MC ;
Marcovina, SM .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1996, 26 (04) :262-267
[2]   FUNCTIONAL EXPRESSION OF HUMAN AND MOUSE PLASMA PHOSPHOLIPID TRANSFER PROTEIN - EFFECT OF RECOMBINANT AND PLASMA PLTP ON HDL SUBSPECIES [J].
ALBERS, JJ ;
WOLFBAUER, G ;
CHEUNG, MC ;
DAY, JR ;
CHING, AFT ;
LOK, S ;
TU, AY .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1258 (01) :27-34
[3]  
Albers JJ, 1999, J LIPID RES, V40, P295
[4]   Stearic acid, trans fatty acids, and dairy fat: Effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects [J].
Aro, A ;
Jauhiainen, M ;
Partanen, R ;
Salminen, I ;
Mutanen, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (05) :1419-1426
[5]  
Beamer LJ, 1998, PROTEIN SCI, V7, P906
[6]   Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution [J].
Beamer, LJ ;
Carroll, SF ;
Eisenberg, D .
SCIENCE, 1997, 276 (5320) :1861-1864
[7]  
Beentjes JAM, 2000, J LIPID RES, V41, P925
[8]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[9]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[10]  
Brown ML, 1990, CURR OPIN LIPIDOL, V1, P122